相关实验视频
Updated: Feb 24, 2026

06:08
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
3.7K
用于药物输送和疾病治疗的外体细胞增大技术:一篇评论
1The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, China.
Biomaterials research
|February 23, 2026
概括
工程外体对疾病的诊断和治疗有希望. 本综述详细介绍了它们的隔离,功能化以及在生物成像和治疗中的先进应用,重点介绍了微流体和体技术.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 细胞生物学 细胞生物学
背景情况:
- 外体是细胞分泌的纳米纤维,对细胞间通信至关重要.
- 功能化外生体正在成为疾病诊断和治疗的强大工具.
- 有限的研究存在于这些修改的纳米的全面获取和应用.
研究的目的:
- 系统地审查增强型外体的隔离,功能化,修饰和应用.
- 总结一下工程外体技术近期的进展.
- 分析外体在诊断和治疗方面的潜力.
主要方法:
- 对外体细胞生产和疾病治疗原则的审查.
- 对外体隔离技术的总结,重点是体和微流体技术.
- 外体细胞功能修饰的分类和总结.
主要成果:
- 工程外体提供了比传统外体更强大的诊断和治疗能力.
- 突破包括生物成像和光热疗法的应用,显著提高了疗效.
- 新兴的技术,如微流体和体显示出对外体工程的巨大潜力.
结论:
- 工程外体体代表了纳米医学的重大进步.
- 微流体和体技术是未来外体体应用的关键推动因素.
- 本综述为开发更复杂,更有效的基于外体细胞的诊断和治疗策略提供了见解.
相关概念视频
Overview of Exosomes
3.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.8K
Site-Targeted Drug Delivery Systems: Polymeric Carriers
39
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
39
Drug Delivery: Overview
992
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
992
Modified-Release Drug Delivery Systems: Overview
41
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
41
Vesicular Trasport: Endocytosis, Transcytosis and Exocytosis
3.9K
Vesicular transport is a cellular process that encompasses the engulfment of particles or dissolved substances by cells. It involves endocytosis, transcytosis, and exocytosis.
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
Endocytosis is a cellular mechanism that involves the inward folding of the cell membrane to create vesicles that capture and transport large drug molecules. This process comprises two distinct methods: pinocytosis (often referred to as "cell drinking") and phagocytosis (often referred to as "cell...
3.9K
Modified-Release Drug Delivery Systems: Site-Targeted
33
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
33

